scholarly journals Fibrocellular non‐specific interstitial pneumonia with favourable prognosis in clinically amyopathic dermatomyositis

2016 ◽  
Vol 4 (5) ◽  
Author(s):  
Takahiro Yoshizawa ◽  
Keishi Sugino ◽  
Kazutoshi Shibuya ◽  
Toshimasa Uekusa ◽  
Sakae Homma
2016 ◽  
Vol 43 (9) ◽  
pp. 1735-1742 ◽  
Author(s):  
Hua Cao ◽  
Qunli Xia ◽  
Meng Pan ◽  
Xiaoqing Zhao ◽  
Xia Li ◽  
...  

Objective.Gottron papules and Gottron sign are characteristic and possibly pathognomonic cutaneous features of classic dermatomyositis and clinically amyopathic dermatomyositis (DM/CADM). However, the Gottron papules/Gottron sign with cutaneous ulceration (ulcerative Gottron papules/Gottron sign) are less common. We aimed to clarify the clinical characteristics of patients with DM/CADM who have ulcerative Gottron papules/Gottron sign.Methods.Clinical features, laboratory findings, and prognosis of patients with DM/CADM who had Gottron papules/Gottron sign with or without ulceration were analyzed and compared.Results.Occurrences of acute interstitial pneumonia/subacute interstitial pneumonia (AIP/SIP) were significantly higher in patients with ulcerative Gottron papules/Gottron sign (19/26) versus patients with Gottron papules/Gottron sign without ulceration (2/66, p < 0.001). We also observed that the white blood cell counts (mean ± SD 4.2 ± 1.6 vs 6.9 ± 2.9; p < 0.001) and creatine kinase (CK) levels (198.0 ± 377.7 vs 1364.0 ± 2477.0; p = 0.019) were significantly lower, whereas the positive rate of antimelanoma differentiation-associated gene 5 antibody (anti-MDA5; 88.5% vs 6.1%, p < 0.001) and serum ferritin levels (665.2 ± 433.5 vs 256.2 ± 279.0, p < 0.001) were significantly higher in the patients with ulcerative Gottron papules/Gottron sign. Moreover, the cumulative survival rate of the group with ulcerative Gottron papules/Gottron sign was significantly lower (p < 0.001).Conclusion.Patients with DM/CADM who have ulcerative Gottron papules/Gottron sign, positive anti-MDA5 antibody, and significantly lower baseline CK level are at increased risk of interstitial lung disease, especially AIP/SIP. A new designation for this subgroup of patients should be established to draw more attention to this clinical entity.


2018 ◽  
Vol 57 (13) ◽  
pp. 1935-1938 ◽  
Author(s):  
Mizuki Yagishita ◽  
Yuya Kondo ◽  
Toshihiko Terasaki ◽  
Mayu Terasaki ◽  
Masaru Shimizu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document